A Phase I/II study, led by investigators at The University of Texas MD Anderson Cancer Center, reports an investigational drug called tagraxofusp has demonstrated high response rates in patients with blastic plasmacytoid ...
Nov 14, 2018
0
3
Geneticists at St. Jude Children's Research Hospital have discovered a previously unknown cell growth mechanism that makes a wide range of cancers resistant to rapamycin and related drugs. The finding offers the promise of ...
Sep 12, 2018
0
28
Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or ...
Jul 30, 2018
0
5
A deadly feature of acute lymphoblastic leukemia (ALL) is its invasion of the central nervous system.
Jul 18, 2018
0
52
A team of researchers with members affiliated with several institutions in the U.S. has found that some statins could enhance the efficacy of a chemotherapy drug used to fight blood cancers in mouse models. In their paper ...
It's time to move beyond the traditional "magic bullet" approach for discovering new drugs and start leveraging the full complexity of Mother Nature, according to Vanderbilt Professor of Chemistry Brian Bachmann and Assistant ...
May 3, 2018
0
13
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Washington University School of Medicine in St. Louis shows. ...
Apr 24, 2018
0
62
An international research consortium led by researchers from the University of Helsinki, Finland, has discovered new information related to a rare form of leukemia called aggressive NK-cell leukemia. Potential new treatment ...
Apr 19, 2018
0
0
In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide (small protein) drug shows promise against the often-lethal cancer acute ...
Apr 11, 2018
0
281
Physicians who received payment from pharmaceutical companies for meals, talks and travel were more likely to prescribe those companies' drugs for two cancer types, a University of North Carolina Lineberger Comprehensive ...
Apr 9, 2018
0
1
